ProCE Banner Activity

What’s New With Targeted Therapy for Advanced Cholangiocarcinoma: Reports From ASCO 2022

Clinical Thought
Read this commentary for an overview of recent advances in targeted therapies for cholangiocarcinoma, including key abstracts presented at the 2022 American Society of Clinical Oncology Annual Meeting.

Released: August 03, 2022

Expiration: August 02, 2023

No longer available for credit.



Nina Beri

Nina Beri, MD

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner


Supported by educational grants from

Bayer Healthcare Pharma

Incyte Corporation

Faculty Disclosure

Primary Author

Nina Beri, MD

Nina Beri, MD, has no relevant financial relationships to disclose.